Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medileech for Rhizarthrosis
NCT03020368Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Randomised, single-blind trial in Rhizarthrosis (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Disabilities of the Arm, Shoulder and Hand at 56 days. Started Jan 2017; status: terminated.
02
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on NCT03020368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020368.